This page is provided for research and educational purposes only and does not provide medical advice, diagnosis, treatment recommendations, dosing instructions, or instructions for human use. Research findings should be interpreted within the population, model, formulation, route, outcomes, and study design reported by each cited source.
Gonadorelin (2 mg Vial)
Gonadorelin dosage supports the restoration of natural LH and FSH release from the pituitary gland, reactivating the hypothalamic-pituitary-gonadal (HPG) axis[1]. As a synthetic form of gonadotropin-releasing hormone (GnRH), gonadorelin stimulates testosterone production in men and promotes ovulation in women when administered in short, pulsatile doses[2][3].
Quick Reference
What is Gonadorelin?
Research overview based on the cited scientific literature.
• Goal: Stimulate endogenous LH and FSH release to support testosterone production and testicular function[1][5].
• Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.
Storage Instructions
Proper storage preserves peptide quality.
• Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure.
• Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 4 weeks and avoid freeze–thaw.
• Allow vials to reach room temperature before opening to reduce condensation uptake.
How is Gonadorelin studied?
Gonadorelin is a synthetic decapeptide identical to endogenous gonadotropin-releasing hormone (GnRH) secreted by the hypothalamus[1]. When administered in short, pulsatile fashion, it binds to GnRH receptors on pituitary gonadotrophs, triggering the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH)[2][3]. LH stimulates Leydig cells to produce testosterone in men and triggers ovulation in women, while FSH supports spermatogenesis and ovarian follicle development[5]. Unlike continuous GnRH agonist administration, which desensitizes receptors and suppresses gonadotropins, brief periodic dosing preserves the natural pulsatile signaling pattern[4][6].
What does the research report about Gonadorelin?
Observations from clinical and preclinical literature.
• Supports endogenous testosterone production by stimulating LH release[1][5].
• May help maintain testicular volume and function during exogenous testosterone therapy[7].
• Promotes spermatogenesis and fertility in hypogonadotropic hypogonadism when administered in pulsatile regimens[8][9].
• Generally well tolerated; occasional mild injection-site reactions (redness, itching, or swelling) may occur[10].
• Possible transient headache or flushing shortly after injection[10].
Research Limitations / Risk Notes
Extended continuous administration may lead to GnRH receptor desensitization and reduced LH/FSH response[4]. Brief periodic dosing preserves the natural pulsatile signaling pattern, while continuous GnRH agonist administration can desensitize receptors and suppress gonadotropins[4][6].
Important Note
This content is provided for scientific research and educational purposes only. It does not provide medical advice, diagnosis, treatment, dosing, or administration instructions. The compounds discussed may be investigational and are not presented as approved for human use.